🔗 Permalink

Inventor profile of:

Daniel Scherman

City:

Paris

Country:

France

Published Applications:

Last publication date:

2020-11-26

Top Assignees for applications by Daniel Scherman

The entities that hold a legal rights for patent applications filed by inventor Scherman Daniel:

Centre National de la Recherche Scientifique (CNRS 9 Paris, France
UNIVERSITE PARIS DESCARTES 9 Paris, France
Assistance Publique-Hopitaux De Paris 5 Paris, France
GENETHON 5 Evry, France
Universite d'Evry-Val-d'Essonne 4 Evry Cedex, France
Centelion 4 Vitry Sur Seine, France
CNRS-Centre National de la Recherche Scientifique 3 Paris, France
Assistance Publique Hopitaux De Paris 3 Paris 4eme, France
INSERM INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) 3 Paris, France
Institut National De La Sante Et De La Recherche Medicale (INSERM) 3 Paris, France
Association Francaise contre les Myopathies 3 Paris, France
ENSCP—Chimie ParisTech—Ecole Nationale Superieure de Chimie de Paris 2 Paris, France
Institut National de la Sante et de la Recherche Medicale 2 Paris, France
ENSCP - Chimie ParisTech - Ecole Nationale Superieure de Chimie de Paris 2 Paris, France
CNRS (CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE) 2 Paris 16, France
ECOLE NATIONALE SUPERIEURE DE CHIMIE DE PARIS 2 Paris, France
Universite D'Evry Val D'Essonne 2 Evry, France
Institute National de la Sante et de la Recherche Medicale (INSERM) 2 Paris, France
GENETHON 1 Evry, France
ENSCP—CHIMIE PARIS TECH—ECOLE NATIONALE SUPERIEURE DE DE CHIME DE PARIS 1 Paris, France
Institut Gustave Roussy 1 Villejeuif Cedex, France
CNRS (Centre National de la Racherche Scientifique 1 Paris 16, France
Centelion 1 , France
INSERM (Institute National de la Sante et de la Recherche Medicale 1 Paris, France
Centre National de la Recherche Scientifique, C.N.R.S. 1 , France
Centre Ntional de la Recherche Scientifique (CNRS) 1 Paris, France
INSTITUTE PASTEUR 1 Paris, France
ENSCP - Chimie ParisTech - Ecole Nationale Superie ure de Chimie de Paris 1 Paris, France
Gencell, S.A. 1 , France
Institut National de la Sante et de la Recherche M edicale (INSERM) 1 Paris, France
INSERM (Institute National de la Sante et de la Recherche Medicalc) 1 Paris, Cedix 13, France
ENSCP—CHIMIE PARISTECH—ECOLE NATIONALE SUPERIEURE DE CHIME DE PARIS 1 Paris, France
Institut de Recherche pour le Developpement (IRD) 1 Marseilles, France
INSERM (Institut National de la Sante et de la Rec herche Medicale) 1 Paris, France
Institut National de la Sante et de la Receherche Medicate (INSERM) 1 Paris, France
Institut de Recherche pour le Developpement (IRD) 1 Marseille, France
Universite Rene Descartes 1 Paris, France
Universites Paris Descartes Institut National de la Sante et de la Recherche Medicale (Inserm) 1 Paris, France
ENSCP—Chimie Paris Tech—Ecole National Superieure de Chimie de Paris 1 Paris, France
INSERM (Institut National de la Sante et de la Racherche Medicale) 1 Paris, France
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE 1 PARIS, France
Aventis Pharma S.A. 1 Antony Cedex, France

Recent patent applications by Scherman Daniel

Daniel Scherman from Paris, FR has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2020-11-26

US20200368373A1

Human necessities

OPTICAL IMAGING AGENTS TARGETING INFLAMMATION

#2 | 2020-09-17

US20200291402A1

Chemistry; metallurgy

Methods for the treatment of Leber congenital amaurosis

#3 | 2019-06-27

US20190192430A1

Human necessities

Gelling compositions for treating malignant tumours and/or preventing tumour recurrence

#4 | 2018-01-18

US20180016579A1

Chemistry; metallurgy

Methods for the treatment of Leber congenital amaurosis

#5 | 2017-02-16

US20170044533A1

Chemistry; metallurgy

Methods for the treatment of Leber congenital amaurosis

#6 | 2016-11-17

US20160333022A1

Chemistry; metallurgy

Water soluble 4-azapodophyllotoxin analogs

#7 | 2015-04-23

US20150111951A1

Chemistry; metallurgy

Methods for the treatment of leber congenital amaurosis

#8 | 2014-12-18

US20140371575A1

Human necessities

Persistent luminescence nanoparticles excitable in situ for in vivo optical imaging, in vivo multimodal optical—MRI imaging, and theranostics

#9 | 2014-10-30

US20140323400A1

Chemistry; metallurgy

Use of fibromodulin and lumican for increasing muscle mass

#10 | 2014-06-26

US20140179767A1

Chemistry; metallurgy

Methods for the treatment of Leber congenital amaurosis

#11 | 2013-09-12

US20130236426A1

Human necessities

Use of decorin for increasing muscle mass

#12 | 2013-05-23

US20130129767A1

Chemistry; metallurgy

Vaccines against pregnancy-associated malaria

#13 | 2012-04-19

US20120093915A1

Human necessities

Vectors including an anionic macromolecule and a cationic lipid for delivering small nucleic acids

#14 | 2012-03-08

US20120058955A1

Human necessities

USE OF DECORINE FOR INCREASING MUSCLE MASS

#15 | 2011-12-29

US20110319605A1

Chemistry; metallurgy

Purification of a triple helix formation with an immobilized obligonucleotide

#16 | 2011-06-02

US20110129487A1

Chemistry; metallurgy

Plasmic production and expression of recombinant proteins in cells grown without antibiotics

#17 | 2010-05-27

US20100129371A1

Human necessities

Method for genetic immunization by electrotransfer against a toxin and antiserum obtainable by said method

#18 | 2010-01-14

US20100010208A1

Chemistry; metallurgy

Purification of a triple helix formation with an immobilized oligonucleotide

#19 | 2009-06-18

US20090155173A1

Physics

Persistent luminescence nanoparticles used in the form of a diagnosis agent for in vivo optical imaging

#20 | 2008-07-31

US20080183123A1

Chemistry; metallurgy

Methods and devices for delivering a therapeutic product to the ocular sphere of a subject

#21 | 2007-11-01

US20070255041A1

Human necessities

Bioengineered Vehicles for Targeted Nucleic Acid Delivery

#22 | 2006-05-02

US10275071

Purification of a triple heli formation with an immobilized oligonucleotide

#23 | 2006-02-16

US20060036085A1

Chemistry; metallurgy

Purification of a triple helix formation with an immobilized oligonucleotide

#24 | 2006-01-12

US20060009403A1

Human necessities

Dna demethylase antisense and chemotherapy combination

#25 | 2005-12-29

US20050289658A1

Chemistry; metallurgy

System for regulating in vivo the expression of a transgene by conditional inhibition

#26 | 2005-10-06

US20050222434A1

Chemistry; metallurgy

Acid-sensitive compounds, their preparation and uses

#27 | 2005-09-06

US9986033

Method for transferring nucleic acid into striated muscles

#28 | 2005-04-21

US20050085426A1

Chemistry; metallurgy

Acid-sensitive compounds, preparation and use thereof

InventorID:

260948 ⎘